Cancer Survivorship, Developmental Therapeutics Program, Pediatric Oncology, Pediatric Musculoskeletal Tumor Program, Young Women’s Blood Disorders Program, Pediatric Stem Cell Transplant Program, Cancer Susceptibility Program, Pediatric Hematology, Pediatric Brain Tumor Program, Bleeding Disorders Treatment Program, Pediatric Sickle Cell Disease Program, Bone Marrow Failure Program, CAR T-Cell Therapies for Pediatric Cancers, Vascular Anomalies, Pediatric Gene Therapy Program
Pediatric cancer, Pediatric ependymoma, Pediatric extramedullary hematopoiesis, Pediatric medulloblastoma, Retinoblastoma in Children, Sarcomas in children, Pediatric glioblastoma, Leukemia in children, Pediatric lymphoma, Pediatric neurofibromatosis (NF), Rhabdomyosarcoma in children, Pediatric bleeding disorders and thrombosis, Pediatric hemarthrosis, Pediatric genitourinary cancer, Pediatric neuroblastoma, Pediatric Ewing sarcoma, Pediatric osteosarcoma, Non-rhabdomyosarcoma soft tissue sarcoma in children, Osteochondroma in children, Pediatric Wilms tumor (nephroblastoma), Pediatric pilocytic astrocytoma, Pediatric anaplastic astrocytoma, Pediatric anemia, Synovial Sarcoma
Pediatric metaiodobenzylguanidine (MIBG) for neuroblastoma, Pediatric stem cell transplant, Pediatric CAR T-cell therapy, Pediatric gene therapy for blood disorders, Cancer and Hematology Therapy
As the largest childhood cancer and blood disorders center in North Texas, we treat one in five children in Texas diagnosed with cancer.